关于抗莱什曼病复合疫苗的最新情况
Shital Shital1, Evanka Madan2, Angamuthu Selvapandiyan1
1Department of Molecular Medicine, Jamia Hamdard, India.
The Indian journal of medical research
|December 5, 2024
概括
开发针对莱什马尼亚寄生虫的复合疫苗对于对抗莱什马尼亚病 (VL,CL,MCL) 至关重要. 本综述分析了疫苗的成功,挑战和新型的输送系统,以提高免疫性和消除疾病.
科学领域:
- 寄生虫学的寄生虫学
- 免疫学 免疫学 免疫学
- 疫苗开发 疫苗开发
背景情况:
- 莱什曼病是一种显著的寄生性疾病,具有内脏 (VL),皮肤 (CL) 和粘膜皮肤 (MCL) 形式.
- 针对Leishmania物种,已经探索了各种疫苗候选物,包括蛋白质,DNA,载体,辅助剂和重组整体寄生虫.
- 一些Leishmania疫苗候选人已经进入人类临床试验.
研究的目的:
- 审查开发针对莱什马尼亚寄生虫的复合疫苗的所有努力.
- 分析成功,包括商业犬类疫苗,并确定疫苗开发中的挑战.
- 探索疫苗输送系统的进步,以提高免疫性和向抗原输送.
主要方法:
- 关于莱什马尼亚疫苗候选人的实验和临床前研究的全面审查.
- 来自Leishmania疫苗的人类临床试验数据的分析.
- 检查新的疫苗输送系统,如病毒载体和非致病性细菌.
主要成果:
- 已经开发和测试了几种复合疫苗策略,其中一些显示出承诺并进入临床试验.
- 商业上可用的狗疫苗证明了开发有效的莱什马尼亚疫苗的可行性.
- 传递系统的进步,如病毒载体和细菌,为提高疫苗疗效提供了潜力.
结论:
- 了解过去和当前的疫苗开发工作是改进未来战略的关键.
- 新型传递系统有望增强免疫原性并实现对莱什马尼亚的长期免疫反应.
- 持续的研究和开发对于最终控制和根除莱什曼病症至关重要.
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...